Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending May 21, 2022 (Week 20)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †
U.S. Residents, excluding U.S. Territories 136 458 4,997 3,203 4 14 120 68
New England - 17 119 133 - 1 1 -
Connecticut - 6 29 36 - 0 - -
Maine - 7 36 31 - 0 - -
Massachusetts - 9 - 41 - 0 - -
New Hampshire - 4 25 12 - 1 1 -
Rhode Island - 4 19 9 - 1 - -
Vermont - 3 10 4 - 0 - -
Middle Atlantic 47 86 798 457 3 6 30 16
New Jersey 3 12 78 83 3 3 14 16
New York (excluding New York City) 22 46 303 130 - 2 10 -
New York City 12 22 184 125 - 6 - -
Pennsylvania 10 19 233 119 - 2 6 -
East North Central 6 92 947 471 - 4 36 9
Illinois N NC N N N NC N N
Indiana 3 28 188 152 - 0 - -
Michigan 1 18 170 109 - 2 4 3
Ohio - 41 436 204 - 4 32 6
Wisconsin 2 19 153 6 - 0 - -
West North Central 9 32 319 168 - 2 11 18
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 0 - - - 0 - -
Missouri 4 20 209 108 - 2 11 10
Nebraska 5 7 51 26 - 0 - -
North Dakota - 4 23 13 - 0 - -
South Dakota - 7 36 21 - 1 - 8
South Atlantic 13 73 563 565 - 5 9 5
Delaware 1 5 38 20 - 0 - -
District of Columbia - 2 9 8 - 0 - -
Florida 12 26 257 196 - 3 8 3
Georgia - 18 34 174 - 0 - -
Maryland - 11 15 82 - 0 - 1
North Carolina N NC N N N NC N N
South Carolina - 25 181 1 - 3 1 1
Virginia - 2 5 6 - 0 - -
West Virginia - 11 24 78 - 0 - -
East South Central 17 45 453 362 - 2 2 2
Alabama 3 19 127 95 - 1 1 -
Kentucky 3 12 82 39 - 2 1 2
Mississippi 3 8 68 60 - 0 - -
Tennessee 8 28 176 168 - 0 - -
West South Central 4 127 574 386 - 5 12 14
Arkansas 1 10 84 48 - 1 1 -
Louisiana - 29 69 102 - 2 2 -
Oklahoma N NC N N N NC N N
Texas 3 117 421 236 - 5 9 14
Mountain 38 94 1,142 603 - 3 13 4
Arizona 26 48 532 260 - 1 2 2
Colorado 9 28 244 118 - 1 2 -
Idaho N NC N N N NC N N
Montana - 5 34 24 - 1 - -
Nevada - 10 102 72 - 1 1 1
New Mexico 1 16 144 61 - 0 - -
Utah 2 12 86 48 - 2 8 1
Wyoming - 3 - 20 - 0 - -
Pacific 2 12 82 58 1 2 6 -
Alaska 2 11 71 47 1 2 6 -
California N NC N N N NC N N
Hawaii - 3 11 11 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - 1 - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - 1 - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 136 458 4,997 3,204 4 14 120 68
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.